Drug-induced disorders of glucose tolerance

MK Pandit, J Burke, AB Gustafson… - Annals of internal …, 1993 - acpjournals.org
Purpose: To review the medications that influence glucose metabolism and to examine the
mechanisms of these medications on glucose metabolism. Data Sources: Data were …

Psychosocial problems in adolescents with type 1 diabetes mellitus

K Kakleas, B Kandyla, C Karayianni… - Diabetes & metabolism, 2009 - Elsevier
Adolescents with diabetes are at increased risk of developing psychiatric (10–20%) or
eating disorders (8–30%), as well as substance abuse (25–50%), leading to non …

Role of gestational hormones in the induction of insulin resistance

EA RYAN, L ENNS - The Journal of Clinical Endocrinology & …, 1988 - academic.oup.com
Pregnancy is associated with insulin resistance. We studied insulin binding and postbinding
function in isolated adipocytes from pregnant and nonpregnant rats. We also used a primary …

Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure …

W Oelkers, JM Foidart, N Dombrovicz… - The Journal of …, 1995 - academic.oup.com
Combined hormonal oral contraceptives (OCs) may lead to a mild rise in blood pressure and
body weight. In rare instances, large increments in blood pressure are measured. We …

Effect of postmenopausal hormone therapy on glucose and insulin concentrations

MA Espeland, PE Hogan, SE Fineberg… - Diabetes …, 1998 - Am Diabetes Assoc
OBJECTIVE To characterize the long-term impact of four hormone therapy regimens on
insulin and glucose concentrations measured during a standard oral glucose tolerance test …

Comparative pharmacology of newer progestogens

H Kuhl - Drugs, 1996 - Springer
The newer progestogens desogestrel, norgestimate, gestodene, dienogest and nomegestrol
share the common property of having weak or no androgenic effects, but there is great …

Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study

M Guido, D Romualdi, M Giuliani… - The Journal of …, 2004 - academic.oup.com
The aim of this study was to investigate the effects of the new estro-progestinic containing
the antimineralcorticoid progestogen drospirenone (DRSP) in women with polycystic ovary …

Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS

HJ Teede, S Hutchison, S Zoungas, C Meyer - Endocrine, 2006 - Springer
Polycystic ovary syndrome is the most common endocrinopathy of reproductive aged
women affecting 6–10% of the population. Traditionally considered a reproductive disorder …

Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome

C Meyer, BP McGrath, HJ Teede - Diabetes care, 2007 - Am Diabetes Assoc
OBJECTIVE—We aimed to determine the impact of medical therapy for symptom
management on insulin resistance, metabolic profiles, and surrogate markers of …

Hormonal contraception

DT Baird, AF Glasier - New England Journal of Medicine, 1993 - Mass Medical Soc
The discovery that progesterone blocked ovulation and the development of the combined
oral contraceptive pill in the 1950s were landmarks in the control of human fertility1, 2. By …